Clinuvel Pharmaceuticals (UR9A.F) Q3 2021 Earnings

26AugConfirmed
Q1 2021
Q3 2021
0.09
0.13
0.18
0.22

Details

Expected EPS
N/A
Actual EPS
0.2216513859219492
Surprise EPS
0.22
Surprise Percent
+∞%

Description

Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.2216513859219492 per share for Q3 2021.

0 Comments

Share your thoughts